What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Marco Racchi spends much of his time researching Biochemistry, Amyloid precursor protein, Endocrinology, Internal medicine and Alzheimer's disease.
The concepts of his Amyloid precursor protein study are interwoven with issues in Acetylcholinesterase, Tacrine, Neuroscience and Metabolism.
His study in Endocrinology is interdisciplinary in nature, drawing from both Fibroblast and Huntingtin, Polyglutamine tract.
His Alzheimer's disease study combines topics from a wide range of disciplines, such as Transmembrane protein, Cell biology, Cortex, Notch signaling pathway and Degenerative disease.
Marco Racchi has researched COS cells in several fields, including Cell, Cell membrane, Reverse cholesterol transport, Lipoprotein and Intracellular.
His work in Disease covers topics such as Cancer which are related to areas like Signal transduction.
His most cited work include:
- Acetylcholinesterase inhibitors: novel activities of old molecules (236 citations)
- Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease (212 citations)
- Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. (178 citations)
What are the main themes of his work throughout his whole career to date?
Marco Racchi focuses on Internal medicine, Endocrinology, Amyloid precursor protein, Disease and Signal transduction.
His research integrates issues of Cell culture and Cell in his study of Internal medicine.
His Endocrinology research incorporates themes from Fibroblast, Protein kinase C, Cytokine and Degenerative disease.
His Amyloid precursor protein study integrates concerns from other disciplines, such as Biochemistry, Neuroscience, Cholinergic and Protein kinase A.
His Disease study incorporates themes from Peripheral, Pathophysiology, Immunology and Oncology.
The study incorporates disciplines such as Receptor, Regulation of gene expression, Neurodegeneration and Kinase in addition to Signal transduction.
He most often published in these fields:
- Internal medicine (32.60%)
- Endocrinology (29.28%)
- Amyloid precursor protein (25.97%)
What were the highlights of his more recent work (between 2014-2021)?
- Receptor for activated C kinase 1 (9.94%)
- Signal transduction (18.78%)
- Neuroscience (16.02%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Receptor for activated C kinase 1, Signal transduction, Neuroscience, Cell biology and Immune system.
His Receptor for activated C kinase 1 research is multidisciplinary, incorporating perspectives in Endocrinology, Internal medicine, Glucocorticoid receptor and Downregulation and upregulation.
The Glucocorticoid research Marco Racchi does as part of his general Endocrinology study is frequently linked to other disciplines of science, such as Dehydroepiandrosterone, therefore creating a link between diverse domains of science.
His Internal medicine research incorporates themes from Depression and Mood.
His Neuroscience study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Neurodegeneration, Disease and Amyloid precursor protein.
His work in Amyloid precursor protein addresses subjects such as Inverse Association, which are connected to disciplines such as Cancer.
Between 2014 and 2021, his most popular works were:
- Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. (178 citations)
- Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors (74 citations)
- Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? (43 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Marco Racchi mainly focuses on Pharmacology, Disease, Endocrinology, Dehydroepiandrosterone and Internal medicine.
He interconnects IC50, Neurodegeneration, Enzyme and Amyloid in the investigation of issues within Pharmacology.
The concepts of his Neurodegeneration study are interwoven with issues in Curcumin, Intensive care medicine and Dementia, Cognitive decline.
His Disease research integrates issues from Gene, Cytotoxic T cell, Free radical scavenger, Neuroscience and Peptide.
Marco Racchi studies Glucocorticoid receptor, a branch of Endocrinology.
His studies deal with areas such as Signal transduction, Gene knockdown and Downregulation and upregulation as well as Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
